Increased HIV-DNA load in CCR5-negative lymphocytes without viral phenotypic change

被引:5
作者
Pakarasang, M
Wasi, C
Suwanagool, S
Chalermchockcharoenkit, A
Auewarakul, P [1 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Prevent & Social Med, Bangkok 10700, Thailand
[3] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Obstet & Gynecol, Bangkok 10700, Thailand
关键词
HIV-DNA; CCR5; relative infectivity; beta-chemokine; RANTES;
D O I
10.1016/j.virol.2005.12.003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have previously described a selective increase in HIV-DNA content in CCR5-negative lymphocytes from late stage HTV-infected patients. Here, we show that this increase occurred even in the absence of viral phenotypic switching from CCR5- to CXCR4-tropic. This leads us to hypothesize that early and late CCR5-tropic viruses might be different in the ability to infect CCR5-low or -negative cells. We compared a set of early CCR5-tropic viruses with low viral DNA content in CCR5-negative cells to a set of late CCR5-tropic viruses with high viral DNA content in CCR5-negative cells. We could not find any significant differences between the two sets of viruses in the aspects of relative infectivity in CCR5-low cells and the level of inhibition by beta-chemokine. This suggested that there may be some changes in cellular phenotype or environment that allows an expansion of susceptible cell population in late stages HIV infection. Understanding these changes may provide a novel approach for HIV therapy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:372 / 378
页数:7
相关论文
共 23 条
[1]   Target cell populations of human immunodeficiency virus type 1 in peripheral blood lymphocytes with different chemokine receptors at various stages of disease progression [J].
Auewarakul, P ;
Sangsiriwut, K ;
Suwanagool, S ;
Wasi, C .
JOURNAL OF VIROLOGY, 2001, 75 (14) :6384-6391
[2]   Increase in activated CD4+ lymphocytes with CCR5 and CXCR4 in HIV type 1-infected persons [J].
Auewarakul, P ;
Sangsiriwut, K ;
Pattanapanyasat, K ;
Suwanagool, S ;
Wasi, C .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (15) :1403-1404
[3]   Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease [J].
Berger, EA ;
Murphy, PM ;
Farber, JM .
ANNUAL REVIEW OF IMMUNOLOGY, 1999, 17 :657-700
[4]   Longitudinal monitoring of 2-long terminal repeat circles in peripheral blood mononuclear cells from patients with chronic HIV-1 infection [J].
Brussel, A ;
Mathez, D ;
Broche-Pierre, S ;
Lancar, R ;
Calvez, T ;
Sonigo, P ;
Leibowitch, J .
AIDS, 2003, 17 (05) :645-652
[5]   Chemokines and HIV-1 second receptors: The therapeutic connection [J].
Cairns, JS ;
D'Souza, MP .
NATURE MEDICINE, 1998, 4 (05) :563-568
[6]   Low levels of co-receptor CCR5 are sufficient to permit HIV envelope-mediated fusion with resting CD4 T cells [J].
Chanel, C ;
Staropoli, I ;
Baleux, F ;
Amara, A ;
Valenzuela-Fernandez, A ;
Virelizier, JL ;
Arenzana-Seisdedos, F ;
Altmeyer, R .
AIDS, 2002, 16 (17) :2337-2340
[7]   Expanded tropism of primary human immunodeficiency virus type 1 R5 strains to CD4+ T-cell lines determined by the capacity to exploit low concentrations of CCR5 [J].
Dejucq, N ;
Simmons, G ;
Clapham, PR .
JOURNAL OF VIROLOGY, 1999, 73 (09) :7842-7847
[8]   Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate [J].
Gorry, PR ;
Taylor, J ;
Holm, GH ;
Mehle, A ;
Morgan, T ;
Cayabyab, M ;
Farzan, M ;
Wang, H ;
Bell, JE ;
Kunstman, K ;
Moore, JP ;
Wolinsky, SM ;
Gabuzda, D .
JOURNAL OF VIROLOGY, 2002, 76 (12) :6277-6292
[9]  
Jansson M, 1999, J HUMAN VIROL, V2, P325
[10]   Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue [J].
Karlsson, I ;
Grivel, JC ;
Chen, SS ;
Karlsson, A ;
Albert, J ;
Fenyö, EM ;
Margolis, LB .
JOURNAL OF VIROLOGY, 2005, 79 (17) :11151-11160